Sharon Engel
13Patents
2h-index
25Co-inventors
54Inventor score
Filing activity: Oct 15, 1998 → Dec 8, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8053603B2 | Tetralone-based monoamine reuptake inhibitors | Chemistry; Metallurgy | 24 | Active |
| US6506884B1 | Variant of vascular endothelial growth factor | Human Necessities | 2 | Expired |
| US6783954B2 | VEGF nucleic acid and amino acid sequences | Human Necessities | 2 | Expired |
| US6630612B2 | 5-HT3 receptor assay using transgenic mammal | Human Necessities | 2 | Expired |
| US8669291B2 | Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors | Chemistry; Metallurgy | 1 | Active |
| US9758529B2 | Fused dihydro-4H-pyrazolo[5,1-C][1,4]oxazinyl compounds and analogs for treating CNS disorders | Chemistry; Metallurgy | 1 | Active |
| US6720182B1 | Alternative splice variants of CD40 | Human Necessities | 1 | Expired |
| US6252131A | Transgenic mammal having 5-HT3 transgene overexpression in the CMS | Human Necessities | 1 | Expired |
| US10562878B2 | Cycloalkylamines as monoamine reuptake inhibitors | Chemistry; Metallurgy | 0 | Active |
| US8877975B2 | Cycloalkylamines as monoamine reuptake inhibitors | Chemistry; Metallurgy | 0 | Active |
| US9868718B2 | Cycloalkylamines as monoamine reuptake inhibitors | Chemistry; Metallurgy | 0 | Active |
| US9586888B2 | Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors | Chemistry; Metallurgy | 0 | Active |
| US8404670B2 | Histamine H3 inverse agonists and antagonists and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.